Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells

Gene Therapy

Volumn 7, Issue 19, 2000, Pages 1613-1623

  Negre D ^a   Mangeot, P E ^a   Duisit, G ^b   Blanchard, S ^a   Vidalain, P O ^a   Leissner, P ^c   Winter, A J ^c   Rabourdin Combe, C ^a   Mehtali, M ^c,d   Moullier, P ^b   Darlix, J L ^a   Cosset, F L ^a  

^a University Lyon i   (France)

^b HÔTEL DIEU   (France)

^c TRANSGENE S A   (France)

^d CRUCELL HOLLAND BV   (Netherlands)

Author keywords

Dendritic cells; Lentiviral vectors; Packaging; Pseudotypes; Retroviruses; Safety

Indexed keywords

B7 ANTIGEN; BOVINE SERUM ALBUMIN; CD1 ANTIGEN; CORE PROTEIN; ENVELOPE PROTEIN; GAG PROTEIN; GENTAMICIN; GLUTAMINE; GLYCOPROTEIN; GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY; PHOSPHATE; PHYCOERYTHRIN; POL PROTEIN; PROPIDIUM IODIDE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SODIUM CHLORIDE; TRANSACTIVATOR PROTEIN; VIRUS DNA; VIRUS PROTEIN; VIRUS VECTOR; ZIDOVUDINE;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DNA PACKAGING; DRUG EFFECT; EMBRYO; EMBRYO CELL; EXPRESSION VECTOR; GENE TARGETING; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; KIDNEY CELL; LENTIVIRINAE; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VIRUS DNA CELL DNA INTERACTION; VIRUS ENVELOPE; VIRUS EXPRESSION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CELL LINE; DENDRITIC CELLS; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; LUMINESCENT PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSFECTION; VIROSOMES;

BOVINAE; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0033763707     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301292     Document Type: Article

References (65)

1. High titer packaging cells producing recombinant retroviruses resistant to human serum
2. The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent
3. Type C retrovirus inactivation by human complement is determined by both the viral genome and producer cell
4. Improved methods of retroviral vector transduction and production for gene therapy
5. Gene delivery systems for use in gene therapy: An overview of quality assurance and safety issues
6. Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma
7. Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences
8. Modifying the host range properties of retroviral vectors
9. Lentiviruses as gene transfer agents for delivery to non-dividing cells
10. Lentiviral vectors: Turning a deadly foe into a therapeutic agent
11. Establishment of parameters for optimal transduction efficiency and antitumor effects with purified high-titer HSV-TK retroviral vector in established solid tumors
12. Highly efficient retroviral-mediated gene transfer into hepatocytes in vivo
13. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
14. Integration of murine leukemia virus DNA depends on mitosis
15. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells
16. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
17. Infection of monocyte/macrophages by human T lymphotropic virus type III
18. Human immunodeficiency virus infection of cells arrested in the cell cycle
19. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes
20. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
21. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
22. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
23. HIV-1 nuclear import: In search of a leader
24. Functional exchange of an oncoretrovirus and a lentivirus matrix protein
25. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
26. Transduction of nondividing cells using pseudo-typed defective high-titer HIV type 1 particles
27. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: Expression and potential for helper virus-free packaging
28. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus
29. Lentivirus vectors using human and simian immunodeficiency virus elements
30. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors
31. Stable gene transfer to the nervous system using a non-primate lentiviral vector
32. Gene transfer vectors derived from equine infectious anemia virus
33. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis
34. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
35. Highly efficient and sustained gene transfer in adult neurons with a lentiviral vector
36. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo
37. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
38. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
39. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
40. Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses
41. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
42. A third-generation lentivirus vector with a conditional packaging system
43. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
44. The 5' RNA terminus of spleen necrosis virus contains a novel postranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production
45. Generation of high-titer pseudo-typed retroviral vectors with very broad host range
46. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates
47. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles
48. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: A possible role for the p2 domain of Gag in RNA encapsidation
49. Retroviral-mediated gene transfer into human CD34+/38- primitive cells capable of reconstituting long-term cultures in vitro and in nonobese diabetic-severe combined immunodeficiency mice in vivo
50. High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocol
51. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells
52. Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes
53. A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines
54. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line
55. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines
56. Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences
57. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines
58. Use of defective HSV-1 vectors harbouring gag, pol, and env genes to rescue defective retrovirus vectors
59. Development of a self-inactivating lentivirus vector
60. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
61. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells
62. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses
63. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dentritic and T cells
64. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells